|
US4626538A
(en)
*
|
1983-06-23 |
1986-12-02 |
American Cyanamid Company |
[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
|
|
US4654347A
(en)
*
|
1983-06-23 |
1987-03-31 |
American Cyanamid Company |
Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
|
|
GB8334210D0
(en)
*
|
1983-12-22 |
1984-02-01 |
Roussel Lab Ltd |
Imidazo(1 2-c)pyrimidines
|
|
GB8613591D0
(en)
*
|
1986-06-04 |
1986-07-09 |
Roussel Lab Ltd |
Chemical compounds
|
|
US4847256A
(en)
*
|
1986-10-16 |
1989-07-11 |
American Cyanamid Company |
4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines
|
|
EP0264773A1
(en)
*
|
1986-10-16 |
1988-04-27 |
American Cyanamid Company |
4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines
|
|
US5059709A
(en)
*
|
1990-11-13 |
1991-10-22 |
American Cyanamid Company |
Process for the synthesis of α-[(dialkylamino)substituted-methylene]-β-oxo-(substituted)propanentriles
|
|
DE4333705C2
(de)
*
|
1993-10-02 |
2003-10-30 |
Guenter Ege |
Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen
|
|
US5538977A
(en)
*
|
1995-03-17 |
1996-07-23 |
American Cyanamid Company |
3-Substituted-7-[3-(imidazol-1-yl)phenyl]-pyrazolo[1,5-a]pyrimidines
|
|
US5714607A
(en)
*
|
1995-12-01 |
1998-02-03 |
American Cyanamid Company |
Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
|
|
US6472528B1
(en)
*
|
1999-08-10 |
2002-10-29 |
Neurocrine Biosciences, Inc. |
Synthesis of substituted pyrazolopyrimidines
|
|
EP1344768B1
(en)
*
|
1999-08-10 |
2005-04-06 |
Neurocrine Biosciences, Inc. |
Synthesis of substituted pyrazolopyrimidines
|
|
US6399621B1
(en)
|
1999-08-10 |
2002-06-04 |
American Cyanamid Company |
N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
|
|
US20030091632A1
(en)
*
|
1999-08-26 |
2003-05-15 |
Neurocrine Biosciences, Inc. |
Controlled-release sedative-hypnotic compositions and methods related thereto
|
|
US6485746B1
(en)
|
2000-08-25 |
2002-11-26 |
Neurocrine Biosciences, Inc. |
Controlled-release sedative-hypnotic compositions and methods related thereto
|
|
DE60011638T2
(de)
*
|
1999-09-02 |
2004-10-21 |
Neurocrine Biosciences Inc |
POLYMORPHE DES N-METHYL-N-(3-(2-THIENYLCARBONYL)-PYRAZOL[1,5-a]PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSTELLUNGEN UND DIESBEZÜGLICHE METHODEN
|
|
US6384221B1
(en)
*
|
1999-09-02 |
2002-05-07 |
Neurocrine Biosciences, Inc. |
Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
|
|
US20040192706A1
(en)
*
|
2002-12-04 |
2004-09-30 |
Janet Codd |
Method and compositions for treating anxiety
|
|
US20060148776A1
(en)
*
|
2003-03-13 |
2006-07-06 |
Conforma Therapeutics Corporation |
Drug formulations having long and medium chain triglycerides
|
|
PL1691811T3
(pl)
|
2003-12-11 |
2014-12-31 |
Sunovion Pharmaceuticals Inc |
Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
|
|
US20050277639A1
(en)
*
|
2004-03-02 |
2005-12-15 |
Phil Skolnick |
2-Pyridinyl[7-(substituted-pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
|
|
US20050245517A1
(en)
*
|
2004-04-29 |
2005-11-03 |
Phil Skolnick |
2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones
|
|
US20060067953A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Conforma Therapeutics Corporation |
Oral pharmaceutical formulations and methods for producing and using same
|
|
CN100528875C
(zh)
*
|
2005-02-18 |
2009-08-19 |
美德（江西）生物科技有限公司 |
无结晶型态的印地普隆及其制备方法
|
|
EP1736475A1
(en)
*
|
2005-06-21 |
2006-12-27 |
Ferrer Internacional, S.A. |
Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
EP2275095A3
(en)
|
2005-08-26 |
2011-08-17 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
AU2006308889A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
GABA receptor mediated modulation of neurogenesis
|
|
US20090247751A1
(en)
*
|
2006-02-20 |
2009-10-01 |
Piramal Healthcare Limited |
Process for the preparation of zaleplon and an intermediate thereof
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
JP2009536667A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス，インコーポレイティド |
５ｈｔ受容体介在性の神経新生
|
|
EP2382975A3
(en)
|
2006-05-09 |
2012-02-29 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
EP1921079A1
(en)
*
|
2006-11-08 |
2008-05-14 |
Ferrer Internacional, S.A. |
Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
|
|
CN101177427B
(zh)
*
|
2006-11-09 |
2011-07-20 |
中国人民解放军军事医学科学院放射与辐射医学研究所 |
一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
|
|
US20090062312A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched indiplon
|
|
US20100029657A1
(en)
*
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
WO2010045615A2
(en)
*
|
2008-10-16 |
2010-04-22 |
Cenomed Biosciences, Llc |
Treatment of organophosphate exposure with ocinaplon
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
CN102174048B
(zh)
*
|
2011-03-08 |
2014-09-17 |
中国人民解放军军事医学科学院放射与辐射医学研究所 |
一种催眠药的新多晶型β
|